|
REPLY TO THREAD
|
|
Subject
|
Synthetic DNA Bacteria Cells in Gulf of Mexico Eating Up Oil, Fish and PEOPLE
|
|
User Name
|
|
|
|
|
|
|
| Font color:
Font:
|
|
|
|
|
|
Original Message
|
THE GULF BLUE PLAGUE
IT’S NOT WISE TO FOOL MOTHER NATURE
It’s not wise to fool Mother Nature. Those who think they can get away with it will abruptly learn that payback can be more than they bargained for. That’s because nature will always retaliate in subtle retorts that shake the very foundations of this earth as well as life itself. Playing the role of Creator is a very dangerous game.
As part of their new logo and corporate image campaign, British Petroleum (BP) wants the public to think of them as their new slogan says, “Beyond Petroleum”. BP is far more than a simple oil company. What is revealed below regarding BP and their ‘beyond petroleum’ activities, both prior to and including their Gulf of Mexico catastrophe, will create a picture for the reader one pixel dot at a time. Once the person who reads everything presented here connects all the dots of the picture, it will be more than obvious that BP has tried to fool Mother Nature… and she’s retaliating with a vengeance that is affecting the entire world. This is a perilous game that has now gotten out of control. What began in the Gulf of Mexico, in February 2010, has now escalated into a man-made biological nightmare of unknown proportions.
SYNTHETIC GENOMICS
On June 13, 2007, BP made a long-term research and development deal and an undisclosed equity investment into a company named Synthetic Genomics Inc. based in Rockville, Maryland. Synthetic Genomics was co-founded by Dr. J. Craig Venter to commercialize genomic-driven technologies. (1) Genomics is the scientific study of the entire DNA sequence of an organism's genome. A genome is all the genetic information in the chromosomes of an organism, including its genes and DNA sequences.
BP/Synthetic Genomics recovered the DNA from subsurface hydrocarbon substrates (biological organisms in crude oil) and applied DNA “sequencing methods” to them. (1) What this means is that they took the DNA from underground crude oil reservoir microbial cells, such as bacteria or viruses, and cultured them in a lab to identify, isolate, and interpret their chemical and genetic properties. Additional “sequencing methods” beyond the initial identity and isolation stages were also carried out.
A central part of the deal between BP and Synthetic Genomics was to create biological transfer processes for crude oil that would lead to improved recovery rates. (1) Their goal was to develop new microbes with lab created genomes that would improve the flow of gas and oil out of a reservoir. For an oil producer like BP, more oil and gas being recovered from a source translates into more profits. This process is known as Microbial Enhanced Oil Recovery (MEOR).
PATENTS PENDING
The BP/Synthetic Genomics alliance was centered on developing new micro-organisms with lab created genomes (synthetic DNA) to improve the outflow of gas and oil reservoirs. That alliance was publicly announced on June 13, 2007. As to what prior date the actual agreement was made is a corporate privacy matter.
However, less than two weeks before the public announcement, on May 31, 2007, US Patent application number 20070122826 was published claiming exclusive ownership of a set of essential genes and a synthetic "free-living organism that can grow and replicate" that is made using those genes. An international patent application at the World Intellectual Property Organization (WIPO number WO2007047148, published April 27, 2007) names more than 100 countries where it may seek monopoly patents. (4)
The company that applied for the patents was the J. Craig Venter Institute (JCVI), a non-profit company founded by genetic scientist J. Craig Venter who also founded Synthetic Genomics, BP’s business alliance partner. Both are based in Rockville, Maryland. By no mere coincidence, Synthetic Genomics Inc. sponsors (pays for) fundamental research at JCVI. (1) Since BP has a developmental and research deal as well as an undisclosed amount of equitable stock ownership with Synthetic Genomics, it’s obvious who’s paying for the synthetic genetic research and results at JCVI.
BP WELLS AT MC252 GULF OF MEXICO
Since they were paying for genetic research to increase oil well flow and production, logic dictates that BP needed to apply a newly created micro-organism(s) produced by their alliance with Synthetic Genomics to the oil reservoir located beneath their Mississippi Canyon Block 252 lease in the Gulf of Mexico. According to BP’s submitted U.S. Minerals Management Service (MMS) application, there were to be two exploration (not production) wells drilled and capped designated as Wells A and B. Exploration wells are commonly used to inject or introduce Microbial Enhanced Oil Recovery micro-organisms and their nutrients into an oil reservoir for increased present and future production.
The first exploration well had been partially drilled by Transocean in October, 2009, but their Marianas semi-submersible drilling rig was damaged by hurricane Ida and was removed for repairs in late November, 2009. On February 3, 2010, the Deepwater Horizon semi-submersible rig commenced exploration drilling to complete the unfinished drilling operation of the Marianas rig. On February 13, 2010, BP informed the MMS that they were experiencing uncontrollable bursts of gas and large cracks at the base of the well. That was the reason they filed for and were granted a permit to abandon and cap the well the same day. (6)
Shortly after, Deepwater Horizon commenced drilling the other exploratory well for BP. We all know the result of the second drilling operation that destroyed the Deepwater Horizon rig on April 22, 2010. One fact that can’t be refuted regarding both exploratory wells is the extreme gas pressures coming from the oil reservoir and the resulting cracks on the ocean floor.
As noted above, MEOR micro-organisms can be applied to an oil reservoir where they grow between the oil and the well’s rock surface to enhance oil recovery. As a by-product of metabolism, micro-organisms produce carbon dioxide gas and this gas accumulates and displaces the oil by driving it up and out of the ground. At the same time, micro-organisms can break down the viscosity of the oil so that it’s thinner and can flow easier.
The published commercial goal of the BP/Synthetic Genomics alliance was to create new genetically engineered micro-organisms to increase the flow of oil. A public trademark of that research involves man-made genomes [synthetic DNA] controlling new artificial cellular organisms. Because of the vast estimated reserves of oil at MC252 in the Gulf of Mexico, the temperatures involved, and its extreme low oxygen depth, previous known or lab enhanced micro-organisms would not be effective in creating an increased flow of the oil.
One can only imagine what the results would be of a new MEOR synthetic bacteria that had a computer DNA designed capability to replicate itself rapidly in that extreme environment. The outcome would be unpredictable since it had never been tested in those conditions before… or had it?
SAY HELLO TO SYNTHIA
In 2003, JCVI successfully synthesized a small virus that infects bacteria. By 2008, the JCVI team was able to synthesize a small bacterial genome. On May 6, 2010, JCVI revealed they had already created a self-replicating bacterial cell controlled by a chemically synthesized genome they named “synthetic Mycoplasma mycoides JCVI-syn1.0”. (7) This completely synthetic cell with its computer designed genome has absolutely no natural DNA. (1) The etc group from Canada named it Synthia and it contains added watermark chains to identify the genome as artificial. It also has antibiotic resistance indicators. (7) One can only speculate why this artificial bacterium has an inherent programmed capability to resist antibiotics.
This new life form has the ability to replicate itself and organically function in any cell into which it has been introduced. Its DNA is artificial and it’s this synthetic DNA that takes control of the cell and is credited with being the building block of life. This is the first self-replicating synthetic bacterial cell thanks to its computer generated DNA. All of the funding for this came from Synthetic Genomics Inc (1), the company BP has a sizable equity position and alliance with. BP is definitely way beyond petroleum just as their new slogan publicizes.
Why watermark this artificial genome? Doing so makes it identifiable as the unique and patented (privately owned) asset it is. What happens if a human becomes infected with a life-threatening variant bacterial species of Synthia? If you use Penicillin to fight the infection, it won’t do any good. Antibiotic resistance is part of its DNA sequence, so any use of antibiotics would be a waste of time.
What would happen if mankind is contaminated by this self-reproducing artificial life form by contact or by breathing it? Would we become subjective to the DNA of the synthetic cells flowing throughout our bodies? Would the Synthia cells combine with other bacterium within us to create a new deadly bacterium? Since the micro-organism is created and gets its programming from computers, would we become subject to artificial electro-magnetic frequencies recognized by these genomes? There are a lot of questions that need to yet be answered. What matters most is this: Will we find out those answers in time?
Complete article located at [link to worldvisionportal.org]
|
|
Pictures (click to insert)
|
 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | | | Next Page >> |
|
